An subsidiary of Funds advised by Apax Partners LLP will sell Healthium Medtech Ltd., an Indian manufacturer of medical equipment, to Funds managed by KKR.
A special purpose vehicle controlled by KKR-managed funds will make the transaction, acquiring a majority stake in the Healthium group, which includes Healthium. The transaction is anticipated to conclude in the third quarter of 2024, pending the acquisition of a few regulatory clearances. No financial information was provided.
After acquiring Healthium in 2018, the Apax Funds transformed the domestic suture player into a leading worldwide leader in medical devices. The business strengthened its management team by appointing Vishal Maheshwari as CFO and Anish Bafna as CEO with the help of the Apax Funds.
Through internal R&D and M&A, Healthium expanded its range of products to include wound closure devices and consumables and made investments in new businesses, including arthroscopy and advanced wound care. It increased its footprint from 50 to over 90 nations during this time.
About Healthium
It is a medical device firm that was established in India in 1992 that develops, produces, and markets a wide range of surgical products worldwide. Its portfolio includes advanced wound closure solutions, arthroscopy, and wound closure, meeting the demands of a wide range of doctors.
